Neurodegenerative & Central Nervous System(CNS)

Alzheimer’s, Parkinson’s, and other systemic neurodegenerative diseases remain as some of the largest unmet medical needs in therapeutic development. Clinical trial design and execution in these areas are also experiencing a renewed focus as we reimagine how to make trials more patient-centric. Reach out to Halloran’s clinical trial experts to find out how the industry is evolving to meet the demand of finding treatments for these devastating conditions and accelerating development opportunities.